Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 4196  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2000  |  Volume : 45  |  Issue : 3  |  Page : 130-135

A Study On Combination Therapy With Puvasol And Topical Corticosteroid In Psoriasis Vulgaris Involving Scalp

Correspondence Address:
P K Kar

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

The efficacy and safety of betamethsone dipropionate 0.05% with salicylic acid 2% scalp lotion was evaluated in patients with moderate to server scalp psoriasis. Out of 150 patients with scalp psoriasis 75 Patients received PUVASOL alone and 75 patients received PUVASOL along with lotion 0.05% betamethsone dipropionate with 2% salicylic acid scalp application for3 weeks. The erythema, indurations, scales application for 3 weeks treatment course with combination therapy. At the end of therapy, 59(78.6%) of those patients receiving combination therapy had 75% improvement of their scalp psoriasis versus 26(34.6%) nose patients using PUVASOL alone. Complete clearing of the scalp was seen in 28 (37.3%) patients receiving therapy and 10 (13.3%) cases receiving treated with topical betamethasone dipropionate with salicylic acid appears to be safe and an effective treatment for scalp psoriasis.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded139    
    Comments [Add]    

Recommend this journal